Myosin Binding Protein C, Cardiac (MYBPC3) Antibody

Este producto es parte de MYBPC - myosin binding protein C
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Myosin Binding Protein C, Cardiac (MYBPC3) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx318041
tested applications
ELISA, WB

Description

MYBPC3 Antibody is a Rabbit Polyclonal against MYBPC3.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetMyosin Binding Protein C, Cardiac (MYBPC3)
HostRabbit
ReactivityHuman, Mouse
Recommended DilutionWB: 1/500 - 1/5000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
Purity> 95%
PurificationPurified by Protein G.
Size 120 µg
Size 250 µg
Size 3100 µg
Size 4200 µg
Size 51 mg
FormLiquid
Tested ApplicationsELISA, WB
Buffer0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDQ14896
Gene ID4607
NCBI AccessionNP_000247.2, NM_000256.3
OMIM115197
AliasFHC,CMH4,CMD1MM,LVNC10,MYBP-C,cMyBP-C,C-protein cardiac muscle isoform,Cardiac MyBP-C,Myosin-binding protein C, cardiac-type
BackgroundAntibody anti-MYBPC3
StatusRUO

Descripción

MYBPC3 is a crucial component of the sarcomere in cardiac muscles, where it regulates cardiac contractility and stabilizes the structural framework of the thick filament. Through its interactions with myosin and actin, it modulates the force and efficiency of cardiac muscle contraction, playing a central role in maintaining the heart’s mechanical function. Mutations in MYBPC3 are a common genetic cause of hypertrophic cardiomyopathy (HCM), a condition characterized by the abnormal thickening of the heart muscle that can lead to heart failure and arrhythmias. These mutations often result in impaired sarcomere function and contribute to maladaptive cardiac remodeling. Research on MYBPC3 focuses on its role in cardiomyopathy pathogenesis and its potential as a therapeutic target for improving heart function in affected individuals.

Related Products

EH2532

Human MYBPC3(Myosin-binding protein C, cardiac-type) ELISA Kit

Ver Producto
FNab05455

anti- MYBPC3 antibody

Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role.

Ver Producto
P5804

Recombinant Human MYBPC3

Ver Producto